Abstract
Streptococcus pneumoniae is a major pathogen causing community-acquired pneumonia and acute bronchitis. Macrolides, fluoroquinolones (FQs), and, recently, telithromycin (TEL) constitute primary therapeutic options, and rare cases of resistance have been reported. In this report, we describe the emergence of an 5. pneumoniae clinical isolate with high-level TEL resistance (MIC, 256 μg/ml) and simultaneous resistance to FQs. Ongoing studies are oriented to elucidate the precise mechanism of resistance to TEL.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 5800-5803 |
| Number of pages | 4 |
| Journal | Journal of Clinical Microbiology |
| Volume | 43 |
| Issue number | 11 |
| DOIs | |
| State | Published - Nov 2005 |
ASJC Scopus subject areas
- Microbiology (medical)
Fingerprint
Dive into the research topics of 'Emergence of a Streptococcus pneumoniae clinical isolate highly resistant to telithromycin and fluoroquinolones'. Together they form a unique fingerprint.Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS